With A Tablet 10 mg (Lafutidine)

Adult dose

1. Short-term treatment of gastric ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and at bedtime. Clinical trial results for administration for up to 8 weeks showed healing in most patients within 8 weeks, although the healing period may occasionally vary among patients. 2. Short-term treatment of duodenal ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and at bedtime. Clinical trial results for administration for up to 6 weeks showed healing in most patients within 6 weeks, although the healing period may occasionally vary among patients. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10mg of lafutidine orally once daily at bedtime. Clinical trial results for administration for up to 2 weeks showed healing in most patients within 2 weeks, although the healing period may occasionally vary among patients. 4. Combination therapy with antibiotics in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia: The usual dose is 10mg of lafutidine twice (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine orally twice daily.

This medication should not be used in patients with hypersensitivity to its components. In addition, due to the presence of lactose, patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, and glucose-galactose malabsorption should not take it. Patients with a history of drug hypersensitivity, hepatic impairment, renal impairment, dialysis patients, and the elderly should use this medication with caution. This medication may occasionally cause serious allergic reactions, including anaphylaxis, so if symptoms such as difficulty breathing, pale face, or low blood pressure occur during administration, the medication should be stopped immediately, and treatment should be sought. Liver function disorders or jaundice may occur, so regular liver function tests should be conducted, and if abnormalities are found, administration should be halted. Blood-related symptoms such as agranulocytosis or thrombocytopenia may arise, so if symptoms such as pharyngalgia, fever, or general lethargy occur, medical consultation should be sought immediately. Additionally, rare serious side effects such as skin rash, seizures, and heart block have been reported, so any abnormal symptoms should be reported to medical personnel without delay. Various mild side effects such as abdominal pain, diarrhea, headache, insomnia, and dizziness may occur, so careful monitoring is essential when symptoms arise. If a malignant tumor is suspected, this medication may alleviate symptoms or delay diagnosis; therefore, tests should be conducted if symptoms such as weight loss, recurrent vomiting, or hematemesis occur. Elderly patients may have reduced bodily functions, so dosing and intervals should be adjusted, and their condition should be closely monitored. Dialysis patients may experience increased serum drug concentrations, so administration should be started cautiously at a low dose. Pregnant women should take this medication only when the therapeutic benefits outweigh the risks, and breastfeeding women are advised against using this medication as it may be excreted in breast milk. Safety in pediatric patients has not been established, so this medication should not be used in children as a principle. This medication should be stored out of reach of children, and it should not be transferred to another container from its original one. Although carcinogenicity was not observed in animal experiments, hyperplasia of endocrine neurocytes was reported at high doses, and some side effects were observed in reproductive developmental toxicity testing, but there were no malformations.

• Shock
• symptoms of anaphylaxis
• facial pallor
• hypotension
• generalized rash
• difficulty breathing
• liver dysfunction
• jaundice
• agranulocytosis
• pharyngitis

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

White round film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/bottle